Postdoctoral Research Scientist

We are seeking to appoint a Postdoctoral Research Scientist to join Professor Tao Dong’s Cancer Immunology and Immunotherapy group at the CAMS Oxford Institute. The research will focus on identifying and characterising cancer-specific T cells with the potential to cross-react with viral antigens, with the aim of improving understanding of cancer progression and informing new cancer immunotherapy strategies.

You will be responsible for designing and conducting experiments, analysing existing multiomic data from patient cohorts, generating new datasets and developing T cell lines, clones and TCR-T cells for further characterisation. The role also involves analysing scientific data, developing experimental protocols, troubleshooting technical problems, supervising students and visiting researchers, and contributing to publications, presentations and collaborative research projects.

It is essential that you hold, or are close to completing, a PhD/DPhil in T cell immunology (or related discipline), with experience working with human T cells, cell culture and functional phenotyping. Candidates should have experience of single-cell or bulk RNA sequencing and data analysis, high-dimensional flow cytometry, managing independent research and contributing to publications or presentations. Excellent communication, collaboration and research planning skills are also required. Experience working with multiomics platforms and datasets or imaging analysis would be advantageous.

Applications for this vacancy should be made online and you will need to upload a supporting statement and CV. Your supporting statement must explain how you meet each of the selection criteria for the post using examples of your skills and experience. Please restrict your documentation to your CV and supporting statement only. Any other documents will be requested at a later date.

This position is offered full time on a fixed term contract until 31 December 2028 and is funded by the CAMS Core grant.

Only applications received before 12 midday on 25 September 2026 will be considered. Please quote 188518 on all correspondence.